| Product NDC: | 60432-466 |
| Proprietary Name: | Dexamethasone |
| Non Proprietary Name: | Dexamethasone |
| Active Ingredient(s): | .5 mg/5mL & nbsp; Dexamethasone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | ELIXIR |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 60432-466 |
| Labeler Name: | Morton Grove Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA088254 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19830727 |
| Package NDC: | 60432-466-08 |
| Package Description: | 1 BOTTLE, GLASS in 1 BOX (60432-466-08) > 237 mL in 1 BOTTLE, GLASS |
| NDC Code | 60432-466-08 |
| Proprietary Name | Dexamethasone |
| Package Description | 1 BOTTLE, GLASS in 1 BOX (60432-466-08) > 237 mL in 1 BOTTLE, GLASS |
| Product NDC | 60432-466 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Dexamethasone |
| Dosage Form Name | ELIXIR |
| Route Name | ORAL |
| Start Marketing Date | 19830727 |
| Marketing Category Name | ANDA |
| Labeler Name | Morton Grove Pharmaceuticals, Inc. |
| Substance Name | DEXAMETHASONE |
| Strength Number | .5 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |